Boston Medical Center

Contact Details: One Boston Medical Center Place Boston MA 2118 United States of America Tel: Fax: Email: amy.gleason@bmc.org

Loading...

Recent Publications by Boston Medical Center:
New mTOR inhibitor for renal cell cancer. This article presents an in-depth, qualitative assessment of the needs,...	13th November, 2009	Boston Medical Center, Boston, Massachusetts, USA.	Oncology (Williston Park). 2009 Jul;23(8 Suppl):54-6.
Payment reform for safety-net institutions--improving quality and outcomes. This article presents an in-depth, qualitative assessment of the needs,...	6th November, 2009	Department of Pediatrics, Boston Medical Center and Boston University	N Engl J Med. 2009 Nov 5;361(19):1821-3. DOI Direct Link
Bevacizumab for renal cell carcinoma, glioblastoma, and other solid tumors. This article presents an in-depth, qualitative assessment of the needs,...	28th October, 2009	Boston Medical Center, Boston, Massachusetts, USA.	Oncology (Williston Park). 2009 Oct;23(11 Suppl):54-6.
Drug essentials. An alkylating agent for CLL and NHL. This article presents an in-depth, qualitative assessment of the needs,...	28th October, 2009	Boston Medical Center, Boston, Massachusetts, USA.	Oncology (Williston Park). 2009 Apr;23(4 Suppl):55-6.
Drug essentials. Small molecule multitargeted TKI therapy. This article presents an in-depth, qualitative assessment of the needs,...	28th October, 2009	Boston Medical Center, Boston, Massachusetts, USA.	Oncology (Williston Park). 2008 Oct;22(11 Suppl):47-8.
→View more Boston Medical Center research publications.

Press Releases on Boston Medical Center:
U.S. News Media Group and NCQA Release 2009-10 Rankings of America's Best Health Insurance Plans	12th November, 2009	U.S. News Media Group	WASHINGTON, Nov. 12 /PRNewswire/ -- U.S. News Media Group and the National Committee for Quality Assurance (NCQA) today released the fifth annual edition of America's Best Health Insurance Plans
Carefx Named an Innovative Information Access 'Company to Watch' By Leading Market Research Firm	28th October, 2009	Carefx Corporation	SCOTTSDALE, Ariz., Oct. 28 /PRNewswire/ -- Carefx Corporation, a leading provider of interoperable workflow solutions to advance the quality and safety of patient care, is listed among the "
Boston Medical Center Managing H1N1 Flu Vaccination for its Community with Carefx's New Immunization Management Solution	27th October, 2009	Carefx Corporation	SCOTTSDALE, Ariz., Oct. 27 /PRNewswire/ -- Acknowledging the critical role of Centers for Disease Control and Prevention (CDC) guidelines in ensuring the safety and efficacy of H1N1 vaccinations,
Limited English Speaking Patients Closer to Being Guaranteed Quality, Equitable Healthcare	12th October, 2009	Language Line Services	-- Rita Weil, Ph.D., medical interpreter and educator, PA The board will review other applications received and may appoint other members and will work to ensure all stakeholders are involved
Orexigen(R) Therapeutics Phase 2b Trial for Empatic(TM) Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus Comparators in Obese Patients	30th September, 2009	Orexigen Therapeutics, Inc.	-- Adverse events and laboratory findings appeared to be consistent with the individual components of Empatic. There were no serious adverse events attributed by investigators to

BioNews Results for Boston Medical Center:
Jury Still Out on Whether Advanced Technology Can Improve the Outcomes of Patients With Anal Canal Cancer	Cancernetwork.com:  Nov 15 2009 1:11AM Matching: boston medical center
The Medicines Company's Full Analysis of CHAMPION Phase III Data Shows Cangrelor Significantly Improves Patien	Genetic Engineering News:  Nov 15 2009 4:07PM Matching: boston medical center
The Medicines Company's Full Analysis of CHAMPION Phase III Data Shows Cangrelor Significantly Improves Patien	Genetic Engineering News:  Nov 15 2009 2:16PM Matching: boston medical center
The Medicines Company's Full Analysis of CHAMPION Phase III Data Shows Cangrelor Significantly Improves Patien	Freshnews.com:  Nov 15 2009 2:09PM Matching: boston medical center
Pyro Pharmaceuticals Elects Robert Moellering, Jr., M.D. as Chairman of the Scientific Advisory Board	TradingMarkets:  Nov 14 2009 5:24AM Matching: boston medical center
Promote your company here: BioNewsCast - Press Release Distribution	→View more Boston Medical Center news.

Boston Medical Center Clinical Trials:
A Multicenter Randomized Trial Comparing Antiglide and Lateral Plate Fixation in Ankle Fractures

Boston Medical Center Patents:
US Patent No.	Title
7517667	Methods for promoting, inhibiting and detecting toxin entry into cells
5763250	Chimeric toxins
5863891	Chimeric toxins
5932471	DNA encoding chimeric toxin
6309817	Identification of virulence determinants activators in prokaryotic pathogens
→View more Boston Medical Center patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 320 individuals from Boston Medical Center using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 260 times since April 2007, the link to the organisation's website has been followed 0 times

Search for more companies in Boston

Search for more companies in MA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Boston Medical Center